Comparison of Biomarker Modulation by Inhibition of EGFR and/or SRC Family
Status:
Completed
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
The central hypothesis to be tested in this study is that dual blockade of EGFR and Src
pathways or proteins are distinct compared to inhibition of either kinase alone in head and
neck and lung cancers.